References
- Miyanaga M, Takase H, Ohno-Matsui K. Anti-neutrophil cytoplasmic antibody-associated ocular manifestations in Japan: a review of 18 patients. Ocul Immunol Inflammation. 2020:1–6. doi:10.1080/09273948.2020.1712432.
- Matsuo T. Eye manifestations in patients with perinuclear antineutrophil cytoplasmic antibody-associated vasculitis: cases series and literature review. Jpn J Ophthalmol. 2007;51(2):131–138. doi:10.1007/s10384-006-0408-z.
- Ebrahimiadib N, Ma L, Modjtahedi BS, Davoudi S, Rahmani S, Syeda S, et al. Atypical perinuclear anti-neutrophil cytoplasmic antibodies in ocular inflammatory diseases. Ocul Immunol Inflammation. 2018;27(6):1–5. doi:10.1080/09273948.2018.1502787.
- Mansi IA, Opran A, Rosner F. ANCA-associated Small-vessel Vasculitis. Am Fam Practise. 2002;65(8):1615–1620.
- Csernok E, Lamprecht P, Gross WL. Diagnostic significance of ANCA in vasculitis. Nat Clin Pract Rheumatol. 2006;2(4):174–175. doi:10.1038/ncprheum0159.
- Watkins AS, Kempen JH, Choi D, Liesegang TL, Pujari SS, Newcomb C, et al. Ocular disease in patients with ANCA-positive vasculitis. J Ocul Biol Dis Infor. 2010;3(1):12–19. doi:10.1007/s12177-009-9044-4.
- Kubal AA, Perez VL. Ocular manifestations of ANCA-associated vasculitis. Rheum Dis Clin North Am. 2010;36(3):573–586. doi:10.1016/j.rdc.2010.05.005.
- Tauber J, Sainz de la Maza M, Hoang-Xuan T, Foster CS. An analysis of therapeutic decision making regarding immunosuppressive chemotherapy for peripheral ulcerative keratitis. Cornea. 1990;9(1):66–73. doi:10.1097/00003226-199001000-00013.
- Galor A, Thorne JE. Scleritis and peripheral ulcerative keratitis. Rheum Dis Clin North Am. 2007;33(4):835–854. doi:10.1016/j.rdc.2007.08.002.
- Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener’s granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med. 1983;98(1):76–85. doi:10.7326/0003-4819-98-1-76.